Alpharadin, a novel, highly targeted alpha pharmaceutical with a good safety profile for patients with CRPC and bone metastases: Combined safety analyses of phase I and II clinical trials
Year: 2009
Type: article
Authors: Stefan Nilsson, Charles Parker, I.K. Haugen, B. Bolstad, A. Lokna, A. Aksnes, G. O'Bryan-Tear, S. Bruland
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2575349420